BLUE Quick Ratio Analysis

The quick ratio measures a company’s ability to cover its short-term obligations using its most liquid assets (cash, marketable securities, and receivables), with a ratio below 1.0x indicating potential liquidity strain.

At 0.26x, bluebird bio holds only $0.26 in liquid assets for every $1.00 of current liabilities, a level far below the healthcare sector median of 1.46x and placing the company at the 0th percentile among its peers—the worst in the group. Trend data is not available (N/A) because no prior period values exist for the year-over-year or quarter-over-quarter changes. The combination of an extremely low quick ratio with no trend history points to a high short-term liquidity risk that demands close monitoring, though it does not automatically signal a default. This metric contradicts the overall NEUTRAL verdict because such a severe liquidity shortfall typically suggests a bearish stance; however, the neutral rating implies that other factors—such as pipeline potential or cash runway details—offset this immediate concern.

Frequently Asked Questions

Closest Sector Peers